Lantern®
-
Recon
OrthAlign Receives FDA 510(k) Clearance for Lantern® Hip
IRVINE, Calif., Oct. 3, 2024 /PRNewswire/ — OrthAlign, Inc., a privately held medical device company, announces FDA 510(k) clearance of their Lantern…
Read More » -
Recon
OrthAlign Launches Lantern® Handheld Technology for Total, Partial, and Revision Knee Arthroplasty in Japan
IRVINE, Calif., May 14, 2024 /PRNewswire/ — OrthAlign, Inc., a leading innovator in surgical technology, announces the launch of its flagship product,…
Read More » -
Recon
OrthAlign, Inc. Adds Balance Feature to their Lantern® Platform, Including Indications for Primary and Revision Knee Arthroplasty
New feature offers soft-tissue balancing to aid in accurate component positioning ALISO VIEJO, Calif., Nov. 1, 2022 /PRNewswire/ — With its recent…
Read More » -
Recon
OrthAlign Announces the Launch of Lantern®: The Latest Handheld Smart Tool for Knee Replacement Surgery
ALISO VIEJO, Calif., Nov. 12, 2021 /PRNewswire/ — OrthAlign, Inc., a privately held U.S.-based medical device and technology company providing orthopedic surgeons with…
Read More »